The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases
J Liu, Z Liu, Y Pang, H Zhou - Journal of Nanobiotechnology, 2022 - Springer
Nanoparticle (NP) is an emerging tool applied in the biomedical field. With combination of
different materials and adjustment of their physical and chemical properties, nanoparticles …
different materials and adjustment of their physical and chemical properties, nanoparticles …
Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases
JR Nakkala, Z Li, W Ahmad, K Wang, C Gao - Acta Biomaterialia, 2021 - Elsevier
The degree of tissue injuries such as the level of scarring or organ dysfunction, and the
immune response against them primarily determine the outcome and speed of healing …
immune response against them primarily determine the outcome and speed of healing …
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): Diagnosis, treatment, therapy and future perspectives
COVID-19, as an emerging infectious disease, has caused significant mortality and
morbidity along with socioeconomic impact. No effective treatment or vaccine has been …
morbidity along with socioeconomic impact. No effective treatment or vaccine has been …
PLGA particles in immunotherapy
D Horvath, M Basler - Pharmaceutics, 2023 - mdpi.com
Poly (lactic-co-glycolic acid)(PLGA) particles are a widely used and extensively studied drug
delivery system. The favorable properties of PLGA such as good bioavailability, controlled …
delivery system. The favorable properties of PLGA such as good bioavailability, controlled …
Polymer nanotherapeutics: a versatile platform for effective rheumatoid arthritis therapy
Rheumatoid arthritis is an aggressive and severely debilitating disorder that is characterized
by joint pain and cartilage damage. It restricts mobility in patients, leaving them unable to …
by joint pain and cartilage damage. It restricts mobility in patients, leaving them unable to …
Tackling autoimmunity with nanomedicines
X Feng, J Liu, W Xu, G Li, J Ding - Nanomedicine, 2020 - Taylor & Francis
Tolerogenic immunotherapy aims to blunt pathogenic inflammation without affecting
systemic immunity. However, the anti-inflammatory drugs and immunosuppressive biologics …
systemic immunity. However, the anti-inflammatory drugs and immunosuppressive biologics …
Enhancing cancer immunotherapeutic efficacy with sonotheranostic strategies
Immunotherapy has revolutionized the modality for establishing a firm immune response
and immunological memory. However, intrinsic limitations of conventional low responsive …
and immunological memory. However, intrinsic limitations of conventional low responsive …
Amino acid-crosslinked 4arm-PLGA Janus patch with anti-adhesive and anti-bacterial properties for hernia repair
Y Tao, G Jiao, X Zhao, X Tan, L Qiao, R Sheng… - Colloids and Surfaces B …, 2024 - Elsevier
Presently, the non-biodegradable polypropylene (PP) patches frequently used for hernia
repair can cause fibrous tissue growth and adhesions. This study created a Janus Patch with …
repair can cause fibrous tissue growth and adhesions. This study created a Janus Patch with …
The impact of nanocarriers in the induction of antigen-specific immunotolerance in autoimmune diseases
F Dangkoub, M Sankian, M Tafaghodi… - Journal of Controlled …, 2021 - Elsevier
Immunotolerance induction in an antigen-specific manner is the long-term goal of
immunotherapy to treat autoimmune diseases. Nanocarriers (NCs) can be designed as a …
immunotherapy to treat autoimmune diseases. Nanocarriers (NCs) can be designed as a …
[HTML][HTML] Immunomodulatory and immunoregulatory nanomedicines for autoimmunity
J Montano, J Garnica, P Santamaria - Seminars in Immunology, 2021 - Elsevier
Autoimmune diseases, caused by cellularly and molecularly complex immune responses
against self-antigens, are largely treated with broad-acting, non-disease-specific anti …
against self-antigens, are largely treated with broad-acting, non-disease-specific anti …